Clearside Biomedical, Inc. (CLSD) is a publicly traded company in the Unknown sector. Across all available filings, 18 corporate insiders have executed 191 transactions totaling $25.6M, demonstrating a bullish sentiment with $1.3M in net insider flow. The most recent transaction on Jun 24, 2024 involved a purchase of 23,500 shares valued at $24.9K.
No significant insider buying has been recorded for CLSD in the recent period.
No significant insider selling has been recorded for CLSD in the recent period.
Based on recent SEC filings, insider sentiment for CLSD is bullish with an Insider Alignment Score of 53/100 and a net flow of $1.3M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at Clearside Biomedical, Inc. (CLSD) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 18 insiders are actively trading CLSD stock, having executed 191 transactions in the past 90 days. The most active insider is Clay Thorp (Executive), who has made 51 transactions totaling $15.0M.
Get notified when executives and directors at CLSD file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Jun 24, 2024 | Hang Victor Chong Ngai | Executive | Purchase | 23,500 | $1.06 | $24.9K | |
| May 15, 2024 | R. Yerxa Benjamin | Executive | Purchase | 7,813 | $1.31 | $10.2K | |
| Apr 18, 2024 | S. Gibney Anthony | Executive | Purchase | 93,290 | $1.30 | $121.3K | |
| Apr 17, 2024 | S. Gibney Anthony | Executive | Purchase | 6,710 | $1.25 | $8.4K | |
| Mar 20, 2024 | Hang Victor Chong Ngai | Executive | Purchase | 30,000 | $1.60 | $48.0K | |
| Feb 7, 2024 | T. Whitmore Bradford | Executive | Purchase | 444,444 | $1.35 | $600.0K | Large |
| Jan 19, 2024 | A. Deignan Charles | Executive | Sale | 12,900 | $1.28 | $16.5K | |
| Jan 19, 2024 | M. Lasezkay George | Executive | Sale | 18,000 | $1.27 | $22.9K | |
| Nov 1, 2023 | T. Whitmore Bradford | Executive | Purchase | 64,366 | $0.74 | $47.6K | |
| Oct 31, 2023 | T. Whitmore Bradford | Executive | Purchase | 70,812 | $0.73 | $51.7K | |
| Oct 30, 2023 | T. Whitmore Bradford | Executive | Purchase | 600 | $0.69 | $414 | |
| Oct 3, 2023 | J. Hutson Nancy | Executive | Purchase | 10,000 | $0.86 | $8.6K | |
| Sep 25, 2023 | Thorp Clay | Executive | Purchase | 10,000 | $0.86 | $8.6K | |
| Sep 22, 2023 | D. Humphries William | Executive | Option Exercise | 22,727 | $0.40 | $9.1K | |
| Sep 13, 2023 | A. Deignan Charles | Executive | Option Exercise | 34,090 | $0.40 | $13.6K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 44 | $13.5M | 49.0% |
Sale(S) | 101 | $12.1M | 44.1% |
Award(A) | 21 | $1.6M | 6.0% |
Exercise(M) | 9 | $235.0K | 0.9% |
Exercise (Options)(X) | 6 | $1.8K | 0.0% |
Other(J) | 2 | $0 | 0.0% |
Gift(G) | 1 | $0 | 0.0% |
Conversion(C) | 7 | $0 | 0.0% |
Insider activity at Clearside Biomedical, Inc. shows mixed signals across all time. While $13.5M in purchases indicates some executive confidence,$12.1M in sales balances the picture, resulting in a modest net flow of $1.3M.18 insiders have been active, with no strong directional conviction evident in the aggregate data. The most active insider, Clay Thorp, has transacted $15.0M during this period.